Michael Levy, MD, PhD - Publications

Affiliations: 
Neurology Johns Hopkins University, Baltimore, MD 
Area:
Neuromyelitis Optica

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM. Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder. The New England Journal of Medicine. PMID 31050279 DOI: 10.1056/Nejmoa1900866  0.3
2016 Kessler RA, Mealy MA, Levy M. Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic. Current Treatment Options in Neurology. 18: 2. PMID 26705758 DOI: 10.1007/S11940-015-0387-9  0.315
2015 Probasco JC, Hawley G, Burnett M, Gibson L, Carter K, Harlow E, Russell H, Huffman L, Adams J, Ziegler T, Sporney H, Levy M, Puttgen HA. Facilitating Early-In-Day Discharge for Multiple Sclerosis Patients Treated With Intravenous Methylprednisolone: A Quality Improvement Project. The Neurohospitalist. 5: 197-204. PMID 26425247 DOI: 10.1177/1941874415576206  0.309
2015 Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, et al. Update on biomarkers in neuromyelitis optica. Neurology® Neuroimmunology & Neuroinflammation. 2: e134. PMID 26236760 DOI: 10.1212/Nxi.0000000000000134  0.32
2015 Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 85: 177-89. PMID 26092914 DOI: 10.1212/Wnl.0000000000001729  0.316
2014 Levy M. Does aquaporin-4-seronegative neuromyelitis optica exist? Jama Neurology. 71: 271-2. PMID 24424919 DOI: 10.1001/Jamaneurol.2013.5865  0.306
2013 Saini H, Rifkin R, Gorelik M, Huang H, Ferguson Z, Jones MV, Levy M. Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis. Bmc Neurology. 13: 104. PMID 23927715 DOI: 10.1186/1471-2377-13-104  0.515
2012 Mealy MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States: A multicenter analysis Archives of Neurology. 69: 1176-1180. PMID 22733096 DOI: 10.1001/Archneurol.2012.314  0.304
2010 Saini H, Fernandez G, Kerr D, Levy M. Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity. Journal of Neuroimmunology. 221: 68-72. PMID 20227773 DOI: 10.1016/J.Jneuroim.2010.02.007  0.487
2003 Levy M, Faas GC, Saggau P, Craigen WJ, Sweatt JD. Mitochondrial regulation of synaptic plasticity in the hippocampus. The Journal of Biological Chemistry. 278: 17727-34. PMID 12604600 DOI: 10.1074/Jbc.M212878200  0.502
2002 Weeber EJ, Levy M, Sampson MJ, Anflous K, Armstrong DL, Brown SE, Sweatt JD, Craigen WJ. The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. The Journal of Biological Chemistry. 277: 18891-7. PMID 11907043 DOI: 10.1074/Jbc.M201649200  0.595
2002 Schrader LA, Anderson AE, Varga AW, Levy M, Sweatt JD. The other half of Hebb: K+ channels and the regulation of neuronal excitability in the hippocampus. Molecular Neurobiology. 25: 51-66. PMID 11890457 DOI: 10.1385/Mn:25:1:051  0.606
Show low-probability matches.